Provide scientific and hands-on oversight of ligand binding assay (LBA)-based bioanalyses supporting Moderna’s mRNA-LNP therapeutic development programs.
Support and oversee the Immunogenicity function through clinical science-driven, phase-appropriate, and risk-based bioanalytical development strategies across advancing stages of clinical development.
Lead and facilitate anti-drug antibody (ADA) assay and neutralizing antibody assay regulated method development, validation, and clinical sample testing activities.
Ensure in-house GcLP compliance across the LBA team, systems, and procedures, maintaining rigorous laboratory practices and regulatory requirements for analytical activities through a phase-appropriate approach.
Design and execute phase-appropriate clinical analytical strategies supporting development programs.
Drive development, validation, and implementation of:
Cell-based assays
Immunoassays
Quantitation of translated proteins
Pharmacokinetic (PK) assays
Pharmacodynamic (PD) assays
Review and evaluate raw analytical data, assay validation data, and study reports to ensure scientific integrity, data quality, and compliance with current regulatory, industry, and Moderna standards.
Assess analytical performance and laboratory compliance to ensure data generated meet both scientific and regulatory expectations.
Collaborate with internal and external stakeholders to support clinical bioanalytical activities throughout the product development lifecycle.
Contribute to regulatory submissions and support responses to regulatory authority questions and information requests.
Maintain current knowledge of emerging scientific literature, industry best practices, regulatory expectations, and evolving guidance related to clinical bioanalysis.
Ensure adherence to Good Clinical Laboratory Practice (GcLP), Good Laboratory Practice (GLP), Good Clinical Practice (GCP), internal SOPs, applicable regulations, guidance documents, and relevant white papers.
Apply scientific judgment and risk-based decision making to support robust bioanalytical strategies that accelerate development while maintaining quality and compliance.
Partner with multidisciplinary teams to advance innovative analytical approaches and continuously improve laboratory and bioanalytical processes.